Literature DB >> 29681347

Identification of VanB-Type Vancomycin Resistance in Enterococcus gallinarum from Japan.

Yoshikazu Ishii1, Akira Ohno1, Satoko Kashitani2, Morihiro Iwata2, Keizo Yamaguchi3.   

Abstract

In late January 1996, pus obtained from a periproctal abscess on an acute myeloid leukemia patient in Toho University Omori Hospital yielded Enterococcus gallinarum strain TUH327. Antimicrobial susceptibility testing by the agar dilution method showed that this strain was resistant to low levels of vancomycin but remained susceptible to teicoplanin, indicating resistance of the VanC type that is, the intrisic glycopeptide resistance of motile enterococci such as Enterococcus. casseliflavus and E. gallinarum. Subsequently, to confirm the existence of the VanC in E. gallinarum TUH 327, we carried out PCR using primer sets specific to vanA, vanB and vanC. Unexpectedly, results showed the coexistence of vanB and vanC in E. gallinarum TUH327. This appears to be the first reported isolation anywhere in the world of motile enterococci harboring vanB, and also the first report of vanB in any enterococci from Japan.
Copyright © 1996 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Enterococcus gallinarum; VanB; vancomycin resistance

Year:  2014        PMID: 29681347     DOI: 10.1007/BF02350850

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  2 in total

1.  Identification of a Tn1546-like (type 2) element in vancomycin-resistant Enterococcus faecium isolated from hospitalized patients in Japan.

Authors:  R Kariyama; H Kuman; A M Hammerum; F M Aarestrup; L B Jensen
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

2.  Transferable vanB2 Tn5382-containing elements in fecal streptococcal strains from veal calves.

Authors:  Kristin H Dahl; Arnfinn Sundsfjord
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.